Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
26937 | 199 | 49.1 | 82% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | REVERSINE | Author keyword | 11 | 56% | 7% | 14 |
2 | MITOTIC CATASTROPHE | Author keyword | 7 | 18% | 18% | 36 |
3 | WP 631 | Author keyword | 6 | 80% | 2% | 4 |
4 | NEOSIS | Author keyword | 6 | 71% | 3% | 5 |
5 | DEPOLYPLOIDIZATION | Author keyword | 2 | 67% | 1% | 2 |
6 | RAJU CELLS | Author keyword | 2 | 67% | 1% | 2 |
7 | INDUSTRIAL AND OIL POLLUTION | Author keyword | 1 | 100% | 1% | 2 |
8 | CASPIAN ROACH | Author keyword | 1 | 33% | 1% | 2 |
9 | CELL DEATH DETECTION | Author keyword | 1 | 50% | 1% | 1 |
10 | CHECKPOINT CONTROLS | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | REVERSINE | 11 | 56% | 7% | 14 | Search REVERSINE | Search REVERSINE |
2 | MITOTIC CATASTROPHE | 7 | 18% | 18% | 36 | Search MITOTIC+CATASTROPHE | Search MITOTIC+CATASTROPHE |
3 | WP 631 | 6 | 80% | 2% | 4 | Search WP+631 | Search WP+631 |
4 | NEOSIS | 6 | 71% | 3% | 5 | Search NEOSIS | Search NEOSIS |
5 | DEPOLYPLOIDIZATION | 2 | 67% | 1% | 2 | Search DEPOLYPLOIDIZATION | Search DEPOLYPLOIDIZATION |
6 | RAJU CELLS | 2 | 67% | 1% | 2 | Search RAJU+CELLS | Search RAJU+CELLS |
7 | INDUSTRIAL AND OIL POLLUTION | 1 | 100% | 1% | 2 | Search INDUSTRIAL+AND+OIL+POLLUTION | Search INDUSTRIAL+AND+OIL+POLLUTION |
8 | CASPIAN ROACH | 1 | 33% | 1% | 2 | Search CASPIAN+ROACH | Search CASPIAN+ROACH |
9 | CELL DEATH DETECTION | 1 | 50% | 1% | 1 | Search CELL+DEATH+DETECTION | Search CELL+DEATH+DETECTION |
10 | CHECKPOINT CONTROLS | 1 | 50% | 1% | 1 | Search CHECKPOINT+CONTROLS | Search CHECKPOINT+CONTROLS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HELA S3 CELLS | 5 | 25% | 9% | 17 |
2 | NEOSIS | 4 | 67% | 2% | 4 |
3 | REVERSIBLE POLYPLOIDY | 3 | 50% | 2% | 4 |
4 | NEAR SENESCENT | 3 | 60% | 2% | 3 |
5 | INDUCED MITOTIC CATASTROPHE | 3 | 42% | 3% | 5 |
6 | LINEAGE COMMITTED CELLS | 2 | 36% | 3% | 5 |
7 | REVERSINE | 2 | 67% | 1% | 2 |
8 | REVERSINE INCREASES | 2 | 43% | 2% | 3 |
9 | MEIOSIS SPECIFIC GENES | 2 | 28% | 3% | 5 |
10 | SENESCENCE LIKE PHENOTYPE | 2 | 22% | 3% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Death through a tragedy: mitotic catastrophe | 2008 | 206 | 106 | 19% |
Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal | 2013 | 9 | 127 | 18% |
Mechanisms of Drug-Induced Mitotic Catastrophe in Cancer Cells | 2010 | 37 | 83 | 28% |
MOS, aneuploidy and the ploidy cycle of cancer cells | 2010 | 14 | 50 | 36% |
Cell death pathways in response to antitumor therapy | 2009 | 25 | 102 | 22% |
What makes tumors multidrug resistant? | 2007 | 50 | 38 | 13% |
Tumor senescence as a determinant of drug response in vivo | 2002 | 43 | 18 | 22% |
Apoptosis: mediator or mode of cell killing by anticancer agents? | 2001 | 41 | 9 | 44% |
Polyploidy: The Link Between Senescence and Cancer | 2010 | 21 | 86 | 16% |
Giant cell formation: the way to cell death or cell survival? | 2011 | 0 | 52 | 29% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL BIOL CELLULAR | 1 | 50% | 0.5% | 1 |
2 | NIOL MOL BARCELONA | 1 | 50% | 0.5% | 1 |
3 | REGENERAT MED CHEM | 1 | 50% | 0.5% | 1 |
4 | SMALL MOL REGULATORS BIOSYST | 1 | 50% | 0.5% | 1 |
5 | TUM CELL BIOL | 1 | 50% | 0.5% | 1 |
6 | MOL BIOL H8 | 1 | 29% | 1.0% | 2 |
7 | NOVA SCOTIA CANC | 1 | 19% | 1.5% | 3 |
8 | MOL ONCOL EXPT THER EUT | 0 | 33% | 0.5% | 1 |
9 | TENOVUS CANC SCI | 0 | 17% | 1.0% | 2 |
10 | KARAEV PHYSIOL | 0 | 11% | 1.5% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000144117 | ERYTHROID GENES//THERMOBIOL//ACLARUBICIN |
2 | 0.0000132820 | GENOME THEORY//GENOME CHAOS//REPLICATION PATTERN |
3 | 0.0000132312 | CELLULAR SENESCENCE//SENESCENCE//BLSC |
4 | 0.0000123027 | HEMATOL ONCOLWINSHIP CANC//MICROTUBULE ACTIVE DRUGS//PHARMACOLRAMMELKAMP EDUC |
5 | 0.0000097286 | NUCLEAR ACTIN//NUCLEAR MYOSIN I//NUCLEAR MYOSIN |
6 | 0.0000096960 | PDXP//SITEP PHASE UNIT 1//DIOC23 |
7 | 0.0000095475 | THERMORADIOSENSITIZATION//THERMAL RADIOSENSITIZATION//LONG DURATION MILD HYPERTHERMIA |
8 | 0.0000091971 | GLUTATHIONE DOXORUBICIN CONJUGATE//RAT HEPATOMA CELL//SIMULTANEOUS IMMOBILIZATION |
9 | 0.0000088017 | CCNG2//CYCLIN G2//CYCLIN G |
10 | 0.0000087113 | KINETOCHORE//SPINDLE ASSEMBLY CHECKPOINT//MAD2 |